Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

ALFAXALONE 10 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [ALFAXAN]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
&NA; The purpose of this study was to evaluate the effectiveness of the alfaxalone formulation Alfaxan™ as an immersion… 
  • table 1
  • table 2
  • figure 1
  • figure 2
2013
2013
Alfaxalone (3α-hydroxy-5α-pregnane-11, 20-dione) is a neuroactive steroid with anaesthetic properties and a wide margin of safety… 
2013
2013
The aim of this study was to evaluate short-term intravenous anaesthesia with alfaxalone in green iguanas (Iguana iguana… 
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2012
2012
OBJECTIVE To assess the efficacy of alfaxalone as an anaesthetic induction agent for dogs aged less than 12 weeks. MATERIALS… 
2012
2012
OBJECTIVE To assess the clinical suitability of alfaxalone as an anaesthetic induction and maintenance agent for kittens aged… 
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
2012
2012
Alfaxalone is a neurosteroid with general anesthetic properties. His steroid structure, analog with progesterone, might have an… 
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To describe and evaluate the use of Alfaxan-CD as an intravenous anaesthetic in young cats. DESIGN Thirty-five… 
2009
2009
Im Jahr 2008 kamen fur Kleintiere drei neue Wirkstoffe auf den deutschen Markt. Dabei handelt es sich um Alphaxalon (Alfaxan… 
2009
2007
2007
The anesthetic properties of steroid hormones were first identified in 1941, leading to the development of neurosteroids as… 
  • figure 1.1
  • figure 1.2
  • figure 1.3
  • figure 1.4
  • table 1.1